Bank of Montreal
COGT icon

Bank of Montreal’s Cogent Biosciences COGT Stock Holding History

Bank of Montreal’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.47M Buy
38,309
+28,417
+287% +$1.05M ﹤0.01% 1825
2025
Q4 		$351K Sell
9,892
-13,632
-58% -$383K ﹤0.01% 2493
2025
Q3 		$338K Buy
+23,524
New +$279K ﹤0.01% 2472
2025
Q2 		– Sell
-205,030
Closed -$1.23M – 3549
2025
Q1 		$1.23M Buy
+205,030
New +$1.61M ﹤0.01% 1722
2024
Q4 		– Sell
-287,610
Closed -$3.13M – 3568
2024
Q3 		$3.13M Buy
+287,610
New +$2.8M ﹤0.01% 1500
2021
Q4 		– Sell
-131,757
Closed -$1.16M – 3545
2021
Q3 		$1.16M Buy
+131,757
New +$1.01M ﹤0.01% 2392
2019
Q3 		– Sell
-11
Closed – – 4748
2019
Q2 		$0 Buy
11
+10
+1,000% +$133 ﹤0.01% 4880
2019
Q1 		$0 Sell
1
-66
-99% -$1.13K ﹤0.01% 4378
2018
Q4 		$1K Buy
67
+61
+1,017% +$1.8K ﹤0.01% 4512
2018
Q3 		$0 Hold
6
– – ﹤0.01% 4741
2018
Q2 		$0 Buy
+6
New +$288 ﹤0.01% 4732

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Bank of Montreal's COGT Position: Q1 2026 in Review

Bank of Montreal increased its Cogent Biosciences (COGT) stake by 287% in Q1 2026, buying an estimated $1.05M and bringing the position to 38,309 shares worth $1.47M. The position accounts for ﹤0.01% of the portfolio, ranked #1825.

Bank of Montreal first reported a position in COGT in Q2 2018 and has held it in 11 quarters since. The position peaked at $3.13M in Q3 2024. 305 funds tracked by Wall St. Rank hold COGT as of Q1 2026.

  • Bank of Montreal held 38,309 shares of Cogent Biosciences worth $1.47M as of Q1 2026.
  • Bank of Montreal bought 28,417 Cogent Biosciences shares in Q1 2026, an estimated $1.05M.
  • Cogent Biosciences made up ﹤0.01% of Bank of Montreal's portfolio in Q1 2026, its #1825 holding.
  • Bank of Montreal first reported a position in Cogent Biosciences in Q2 2018 and has held it in 11 quarters since.
  • Bank of Montreal's Cogent Biosciences position peaked at $3.13M in Q3 2024.
  • 305 funds tracked by Wall St. Rank held Cogent Biosciences as of Q1 2026.

Based on Bank of Montreal's 13F filing for Q1 2026, filed 13 May 2026.